Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Comment by Straniuson Apr 27, 2017 12:35am
87 Views
Post# 26172301

RE:RE:Alumni what does that amount to

RE:RE:Alumni what does that amount toYou need to look at that in context. They were completing the prototype at the UofRochester and were spending product development costs ($148K) that won't be repeated (other than costs to miniaturize the prototype by Optel later this year). Consulting fees were also heavily influenced by the product development costs ($89K).

Lastly Management fees ($94K) were back end loaded as they paid a total of $116K for the whole year (per Note 8 to the F/S).

If you adjust for the above they spend somewhere in the mid $150K per quarter on a run rate basis.

User image

~S

radar17 wrote:
Kool - you asked about the burn rate.  All you have to do is go check out their Financial Statements. 

For just the 3 months ended Dec 2016 they burned through $431,628 !!  That comes to almost $150K per month.  I'll let you decide if that is good news or bad news.


Bullboard Posts